Christian Klein

Company: Roche

Job title: Head Oncology Programs, Department Head Cancer Immunotherapy Discovery 3

Seminars:

Developing IL2v Based Immunocytokine for Cancer Immunotherapy 12:00 pm

Reviewing the field of immunocytokines Experience with IL2 variant based immunocytokine Understand the rationale for development of PD-1 cis-targeted PD1-IL2v immunocytokine This seminar will be delivered digitally at the eventRead more

day: Day Two